ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.

November 29, 1996

In Brief: Vicent Bono Retires As Investigational Drugs Branch Chief; Weiss to Leave For Walter Reed

January 9, 1981

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

Fogarty Leads Grant Program On World Tobacco Research.

July 6, 2001

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995